Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05963009 · ClinicalTrials.gov registry record · Phase 1

Baxdrostat Bioavailability and Bioequivalence Study

A Phase 1 study of Hypertension, sponsored by AstraZeneca.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target
1
Study location

NCT05963009 is a Phase 1 study of Hypertension that has completed, run by AstraZeneca. The registered enrollment target is 14 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05963009, a Phase 1 study of Hypertension, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The goal of this study was to compare the characteristics of a new tablet formulation versus an oral solution of CIN-107 (baxdrostat) in terms of CIN-107 levels over time in the blood and to compare the effect of food on these parameters in healthy volunteer participants who received the CIN-107 tablet under fed versus fasted conditions.

Conditions Studied

Hypertension

Interventions

  • DRUG baxdrostat (formerly CIN-107) oral solution

Study Locations (1)

Ohio

  • Medpace - Cincinnati

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2020-03-11
Est. Completion 2020-04-29
Phase Phase 1

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05963009

The ClinicalTrials.gov registry entry for NCT05963009 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which baxdrostat (formerly CIN-107) oral solution is the first listed.

NCT05963009 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05963009 about?

NCT05963009 is a clinical study titled "Baxdrostat Bioavailability and Bioequivalence Study". The goal of this study was to compare the characteristics of a new tablet formulation versus an oral solution of CIN-107 (baxdrostat) in terms of CIN-107 levels over time in the blood and to compare the effect of food on these parameters in healthy volunteer participants who received the CIN-107 tab...

What is the current status of trial NCT05963009?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2020-03-11. Estimated completion is 2020-04-29.

What conditions does trial NCT05963009 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05963009?

The interventions under investigation include: baxdrostat (formerly CIN-107) oral solution (DRUG).

Who is sponsoring clinical trial NCT05963009?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05963009 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.